Objective:To retrospectively evaluate the safety

technical success rate

and effectiveness of ultratranscatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC

and to explore the new therapy for SHCC. Methods:To 95 cases carry out hepatic selective arterial angiography for SHCC by CT or MRI be diagnosed and clinical very doubt be SHCC

after was diagnosed by DSA

to transcatheter ultraselective subsegmental feeding artery with microcatheter for tumor

employ ethanol and lipidol (1/1) to full fill embolized 143 tumors. Results:Technical success rate was 100% for the ultraselective subsegmental feeding artery transcatheter and embolizatoin in SHCC

There were no major complications in all cases.Before embolization

the diameter of tumors were 0.5~3cm

average diameter 2.3 cm. after tumors were embolized

average diameter 1.2 cm. The 1

3and 5 year recurrence rates were 19%(18/95)

27%(26/95)

37%(35/95)

and the survival rates were 100%(95/95)

85%(81/95)

67%(64/95) respectively. Conclusion:Its effectiveness was very notable

there were no major complications and recurrence rates was less than surgical resection in ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC

It should become the first selective therapy for SHCC.